Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allegra Faces Increasing Challenges In Rx Drug Arena

This article was originally published in The Tan Sheet

Executive Summary

Obstacles to marketing second generation, non-sedating antihistamine Allegra effectively as a prescription drug have escalated substantially in the past year, according to Aventis
Advertisement

Related Content

Aventis “Contingency Plans” For Allegra Include Outlicensing
Aventis “Contingency Plans” For Allegra Include Outlicensing
Aventis “Contingency Plans” For Allegra Include Outlicensing
Schering: Competitor Switch Of Rx Antihistamine, Nasal Steroid Anticipated
Schering: Competitor Switch Of Rx Antihistamine, Nasal Steroid Anticipated
Schering: Competitor Switch Of Rx Antihistamine, Nasal Steroid Anticipated
Pfizer’s Zyrtec Remains Strong As Rx Antihistamine Market Weakens
P&G Searches For “The Next” Prilosec In The New Year After Strong 2003
Allegra Sales Decline Will Not Prompt OTC Switch, Aventis Says
Allegra Sales Decline Will Not Prompt OTC Switch, Aventis Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS096360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel